News

Prescient Medicine Presenting Two Posters at Penn State Addiction Symposium April 4

Prescient Medicine Presenting Two Posters at Penn State Addiction Symposium April 4

FOR IMMEDIATE RELEASE

Contact: 
Margo Schafer Pelak
Prescient Medicine Media Relations
PR@prescientmedicine.com

Prescient Medicine Presenting Two Posters at Penn State Addiction Symposium April 4

HUMMELSTOWN, Pa., Mar. 31, 2017 -- Prescient Medicine, a leader in Precision Medicine laboratory research and technologies, announced today that it will present two posters at the 3rd Annual Penn State Addiction Symposium April 4, 8 a.m. – 5 p.m., Junker Auditorium, Penn State College of Medicine in Hershey, Pa.

Demographic Analysis of Urine Drug Screens from Centers in NJ, Central PA and Missouri. Prescient Medicinereviewed 278 toxicology screening tests from an addiction center in PA and 1114 from five health facilities in MO and one pain management center in NJ.  We compared the sex, age and type of opioid found in the urine between the two populations and for inpatients compared to outpatients.  Results of the study demonstrated a higher median age for inpatients compared to outpatients. Also, THC was the most frequently confirmed drug for outpatient toxicology screenings (144/999) and inpatient (3/102) toxicology screenings in this population. 

Tapentadol: Potential for Cross-reactivity with Methadone During Toxicology Screening describes a spiking experiment performed by Prescient Medicine researchers to investigate whether methadone metabolites interfered with immunoassay screenings for Tapentadol, a commonly prescribed benzenoid-class analgesic pain reliever. Results of the study demonstrated that methadone interfered at levels as low as 5,000 ng/mL.

Prescient Medicine is a leader in Precision Medicine, an innovative approach using pharmacogenetics to tailor treatment plans to the needs of individual patients. Pharmacogenetics identifies how a person’s genetic profile influences the metabolism of prescribed medications and optimizes their usage. This testing, along with clinical insights, can provide patients and physicians with additional information to enhance personalized care. Prescient Medicine’s advanced genetic testing services can help reduce the risk of addiction and potential overdose in patients who require pain medication or other drugs during addiction recovery.